Immunohistochemistry Market Size, Share, Growth Analysis, By Product(Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains), By Application(Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases), By End-user(Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2224 | Region: Global | Published Date: September, 2024
Pages: 157 |Tables: 89 |Figures: 76

Immunohistochemistry Market Insights

Immunohistochemistry Market size was valued at around USD 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024–2031).

Rapidly increasing prevalence of chronic diseases around the world and high investments in the development of novel diagnostic products and technologies are slated to bolster immunohistochemistry market growth. The growing use of immunohistochemistry in drug discovery and development processes is also expected to offer lucrative new business scope for immunohistochemistry providers going forward. High adoption and acceptance of companion diagnostics are also forecasted to create new opportunities for immunohistochemistry companies in the future. Rapid advancements in diagnostics technologies are also projected to favor immunohistochemistry demand outlook in the long run. On the contrary, the dearth of skilled professionals, high costs of immunohistochemistry equipment, and risk of false positives are some key constraints that could hinder the demand for immunohistochemistry across the study period and beyond. High demand for early diagnosis and growing awareness regarding advanced diagnostic technologies will also create new opportunities for immunohistochemistry providers in the long run. 

US Immunohistochemistry Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024–2031

Global Market Size

USD 2.98 billion

Largest Segment

hospitals and diagnostic laboratories

Fastest Growth

hospitals and diagnostic laboratories

Growth Rate

7.4% CAGR

Global Immunohistochemistry Market by region
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Immunohistochemistry Market Segmental Analysis

Global Immunohistochemistry Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits). Based on Application, the market is segmented into Application Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology), and Forensic applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Immunohistochemistry Market Analysis by Product 

Antibodies are projected to account for a substantial share of the global immunohistochemistry market. Growing investments in drug discovery and development is a prime factor that helps the dominance of this segment. Rising use of monoclonal antibodies, antibody drug conjugates, etc. In multiple healthcare applications is also expected to help this segment maintain its high market share across the forecast period. The high use of antibodies in pathology, neuropathology, and hematopathology applications will also create new opportunities for market growth via this segment. 

On the other hand, the demand for immunohistochemistry kits is projected to surge at an impressive pace over the coming years. The rising use of immunohistochemistry kits in multiple research programs and growing preference for immunohistochemistry kits among researchers around the world are also helping this segment bring in major revenue. Surging investments in multiple medical R&D and convenience and ease of use offered by immunohistochemistry kits will also favor market growth going forward.  

Immunohistochemistry Market Analysis by End User 

Hospitals and diagnostic laboratories are projected to spearhead the demand for immunohistochemistry across the study period owing to rising volume of immunohistochemistry diagnostic tests performed in these establishments. Rising hospitalization rates, growing chronic disease prevalence, and high preference for immunohistochemistry diagnostic tests are also helping this segment maintain its dominant market share.  

Meanwhile, the demand for immunohistochemistry in academic institutes & contract research organizations is projected to increase at an impressive pace going forward. The rapid surge in investments in medical research around the world is a prime factor that helps this segment become an opportune one. Increasing adoption of immunohistochemistry by multiple researchers will also further create new opportunities for market players via this segment. 

Global Immunohistochemistry Market by End-user

To get detailed analysis on other segments, Request For Free Sample Report

Immunohistochemistry Market Regional Insights

North America is projected to account for a dominant share of the global immunohistochemistry market. The presence of a strong medical research infrastructure, supportive government funding for research, and rising demand for early diagnostics are forecasted to create new opportunities for immunohistochemistry market players. The United States is projected to lead the demand for immunohistochemistry in this region owing to the presence of multiple pharmaceutical and biotechnology companies in the country. Canada is also expected to provide lucrative opportunities for immunohistochemistry companies as demand for better diagnostic products increases.  

The Asia-Pacific region is emerging as the fastest-growing market for immunohistochemistry companies in the world. Growing awareness regarding early diagnosis, high demand for advanced diagnostic procedures, and increasing healthcare expenditure are making this region a highly opportune one for all immunohistochemistry companies. Rising spending on medical R&D in countries such as Japan, China, and India along with supportive government funding is expected to bolster the demand for immunohistochemistry in this region. 

Global Immunohistochemistry Market by region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunohistochemistry Market Dynamics

Immunohistochemistry Market Drivers

Growing Incidence of Chronic Diseases 

  • Immunohistochemistry plays a vital role in the diagnostics of multiple chronic diseases, and this is why as the prevalence of chronic diseases increases around the world it is also expected to influentially drive up the demand for immunohistochemistry products and technologies as well.  

Rising Demand for Personalized Medicine 

  • Personalized medicine has gained massive popularity around the world and its growing demand is also expected to benefit market growth. Immunohistochemistry helps in identifying specific molecular markers for tailored treatments, especially in cancers indications such as breast, lung, and colorectal thereby favoring market development.  

Restraints 

High Costs of Immunohistochemistry Equipment and Consumables 

  • Immunohistochemistry products and technologies are quite expensive as they utilize advanced technologies and require substantial investments in research. These high costs limit adoption in establishments with limited spending potential and thereby hurt market growth.  

Dearth of Skilled Professionals 

  • The world is witnessing a major absence of skilled professionals to handle immunohistochemistry operations and products. This dearth of skilled professionals to interpret accurate immunohistochemistry results has led to slowed immunohistochemistry demand outlook in most parts of the world. 

Request Free Customization of this report to help us to meet your business objectives.

Immunohistochemistry Market Competitive Landscape

Investing in the development of immunohistochemistry-based diagnostics will be the most rewarding opportunity for any market player. Creating affordable immunohistochemistry solutions that can be used by establishments with limited budgets will help immunohistochemistry companies expand their business in developing countries going forward. New product launches and collaborations are slated to be popular strategies for all immunohistochemistry companies.

Immunohistochemistry Market Top Player’s Company Profiles

  • F. Hoffmann-La Roche Ltd. 
  • Danaher Corporation 
  • Agilent Technologies Inc. 
  • PHC Holdings Corporation 
  • Thermo Fisher Scientific Inc. 
  • Merck KGaA 
  • Bio-Rad Laboratories, Inc. 
  • Bio-Techne 
  • Becton, Dickinson and Company 
  • Takara Bio Inc. 
  • Enzo Biochem Inc. 
  • Sino Biological, Inc. 
  • Sakura Finetek Japan Co., Ltd. 
  • Cell Signaling Technology, Inc. 
  • BIO SB 
  • Miltenyi Biotec 
  • OriGene Technologies, Inc. 
  • EagleBio 
  • Biocare Medical, LLC 
  • Elabscience Bionovation Inc. 
  • BioGenex 
  • Diagnostic BioSystems Inc. 
  • Histo-Line Laboratories 
  • Rockland Immunochemicals, Inc. 
  • Candor Bioscience GmbH 
  • Genemed Biotechnologies, Inc.

Immunohistochemistry Market Recent Developments

  • Back in March 2023, a new reagent solution for immunohistochemistry was launched by Aptamer Group. Optimer®-Fc was designed to be used in automated immunohistochemistry systems and solutions as use of automation increases in the healthcare industry.  
  • In March 2022, Consortium for Analytic Standardization in Immunohistochemistry (CASI) was launched to improve and oversee the accuracy of immunohistochemistry tests and diagnostics. Boston Cell Standards was the company responsible for the formation of this new organization.  
  • In March 2021, DISCOVERY Green HRP chromogen detection kit was launched by Roche, a leading diagnostics provider. The company launched this new kit to improve immunohistochemistry multiplexing in cancer research to derive more information from tissue samples. 

Immunohistochemistry Key Market Trends

  • Development of Automated Immunohistochemistry Platforms: Automation is projected to be a major trend across all industry verticals in the future. Development of automated immunohistochemistry solutions will also offer highly lucrative opportunities for all immunohistochemistry market players in the future. Use of artificial intelligence will play a vital role in promoting automation.
  • Use of Digital Pathology: As digitization picks up pace in the healthcare industry it is opening new opportunities. Integration of digital pathology with immunohistochemistry is becoming a trend, enabling remote diagnosis, digital slide analysis, and enhanced data management. This also facilitates AI-based image analysis for improved diagnostic accuracy.

Immunohistochemistry Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the future prospects of the immunohistochemistry (IHC) market are promising. Factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, and advancements in diagnostic techniques are expected to drive market growth. Additionally, the growing focus on precision medicine and targeted therapies is fueling the demand for IHC assays in drug development and patient stratification. Technological advancements, such as multiplex IHC and digital pathology, are further enhancing the capabilities of IHC, allowing for more comprehensive analysis and interpretation of tissue samples. Moreover, the expanding applications of IHC in research and clinical settings, along with the emergence of novel biomarkers, present significant opportunities for market expansion. With ongoing advancements and innovations, the IHC market is poised for continued growth in the coming years.

Report Metric Details
Market size value in 2022 USD 2.9 billion
Market size value in 2031 USD 5.5 billion
Growth Rate 7.4%
Base year 2023
Forecast period 2024–2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits)
  • Application
    • Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases)), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology)), and Forensic applications.
  • End-user
    • Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • F. Hoffmann-La Roche Ltd. 
  • Danaher Corporation 
  • Agilent Technologies Inc. 
  • PHC Holdings Corporation 
  • Thermo Fisher Scientific Inc. 
  • Merck KGaA 
  • Bio-Rad Laboratories, Inc. 
  • Bio-Techne 
  • Becton, Dickinson and Company 
  • Takara Bio Inc. 
  • Enzo Biochem Inc. 
  • Sino Biological, Inc. 
  • Sakura Finetek Japan Co., Ltd. 
  • Cell Signaling Technology, Inc. 
  • BIO SB 
  • Miltenyi Biotec 
  • OriGene Technologies, Inc. 
  • EagleBio 
  • Biocare Medical, LLC 
  • Elabscience Bionovation Inc. 
  • BioGenex 
  • Diagnostic BioSystems Inc. 
  • Histo-Line Laboratories 
  • Rockland Immunochemicals, Inc. 
  • Candor Bioscience GmbH 
  • Genemed Biotechnologies, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunohistochemistry Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunohistochemistry Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunohistochemistry Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunohistochemistry Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunohistochemistry Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunohistochemistry Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Immunohistochemistry Market size was valued at around USD 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024–2031).

Investing in the development of immunohistochemistry-based diagnostics will be the most rewarding opportunity for any market player. Creating affordable immunohistochemistry solutions that can be used by establishments with limited budgets will help immunohistochemistry companies expand their business in developing countries going forward. New product launches and collaborations are slated to be popular strategies for all immunohistochemistry companies. 'F. Hoffmann-La Roche Ltd. ', 'Danaher Corporation ', 'Agilent Technologies Inc. ', 'PHC Holdings Corporation ', 'Thermo Fisher Scientific Inc. ', 'Merck KGaA ', 'Bio-Rad Laboratories, Inc. ', 'Bio-Techne ', 'Becton, Dickinson and Company ', 'Takara Bio Inc. ', 'Enzo Biochem Inc. ', 'Sino Biological, Inc. ', 'Sakura Finetek Japan Co., Ltd. ', 'Cell Signaling Technology, Inc. ', 'BIO SB ', 'Miltenyi Biotec ', 'OriGene Technologies, Inc. ', 'EagleBio ', 'Biocare Medical, LLC ', 'Elabscience Bionovation Inc. ', 'BioGenex ', 'Diagnostic BioSystems Inc. ', 'Histo-Line Laboratories ', 'Rockland Immunochemicals, Inc. ', 'Candor Bioscience GmbH ', 'Genemed Biotechnologies, Inc.'

Immunohistochemistry plays a vital role in the diagnostics of multiple chronic diseases, and this is why as the prevalence of chronic diseases increases around the world it is also expected to influentially drive up the demand for immunohistochemistry products and technologies as well.  

Development of Automated Immunohistochemistry Platforms: Automation is projected to be a major trend across all industry verticals in the future. Development of automated immunohistochemistry solutions will also offer highly lucrative opportunities for all immunohistochemistry market players in the future. Use of artificial intelligence will play a vital role in promoting automation.

North America is projected to account for a dominant share of the global immunohistochemistry market. The presence of a strong medical research infrastructure, supportive government funding for research, and rising demand for early diagnostics are forecasted to create new opportunities for immunohistochemistry market players. The United States is projected to lead the demand for immunohistochemistry in this region owing to the presence of multiple pharmaceutical and biotechnology companies in the country. Canada is also expected to provide lucrative opportunities for immunohistochemistry companies as demand for better diagnostic products increases.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Immunohistochemistry Market

Report ID: SQMIG35H2224

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE